Zhejiang Shouxiangu Pharm Co
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products … Read more
Zhejiang Shouxiangu Pharm Co - Asset Resilience Ratio
Zhejiang Shouxiangu Pharm Co (603896) has an Asset Resilience Ratio of 12.10% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how Zhejiang Shouxiangu Pharm Co's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Shouxiangu Pharm Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥381.80 Million | 12.1% |
| Total Liquid Assets | CN¥381.80 Million | 12.10% |
Asset Resilience Insights
- Moderate Liquidity: Zhejiang Shouxiangu Pharm Co has 12.10% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Shouxiangu Pharm Co Industry Peers by Asset Resilience Ratio
Compare Zhejiang Shouxiangu Pharm Co's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Zhejiang Shouxiangu Pharm Co (2015–2024)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Shouxiangu Pharm Co.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 11.01% | CN¥344.69 Million | CN¥3.13 Billion | +9.96pp |
| 2022-12-31 | 1.05% | CN¥30.00 Million | CN¥2.86 Billion | -5.57pp |
| 2021-12-31 | 6.62% | CN¥130.00 Million | CN¥1.96 Billion | +3.68pp |
| 2020-12-31 | 2.94% | CN¥50.00 Million | CN¥1.70 Billion | -11.86pp |
| 2019-12-31 | 14.80% | CN¥198.50 Million | CN¥1.34 Billion | +12.18pp |
| 2018-12-31 | 2.62% | CN¥31.22 Million | CN¥1.19 Billion | -20.91pp |
| 2017-12-31 | 23.53% | CN¥218.00 Million | CN¥926.34 Million | +21.79pp |
| 2016-12-31 | 1.74% | CN¥10.67 Million | CN¥612.10 Million | -0.82pp |
| 2015-12-31 | 2.56% | CN¥15.50 Million | CN¥605.91 Million | -- |